|
| Status |
Public on Mar 28, 2013 |
| Title |
High-throughput transcriptome sequencing of an AML-M2 patient in two stages: primary tumor and remission. |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
In order to detect the transcriptomic differences during chemotherapy treatment of de novo AML, we adopted massively parallel pyrosequencing of mRNAs (RNA-seq) using blood tissues of an patient with AML (FAB subtype M2) in tumor stage and remission stage. We obtained a total of 34.6 and 30.8 million paired reads from the two samples. The RNA-seq data derived from the sample illustrated the differentially expression genes between the two stages.
|
| |
|
| Overall design |
Blood samples of an AML-M2 patient in two stages examined: primary tumor and chemotherapy induced remission.
|
| |
|
| Contributor(s) |
AYang W |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| Submission date |
Mar 28, 2012 |
| Last update date |
May 15, 2019 |
| Contact name |
AYang Wu |
| E-mail(s) |
13906969368@139.com
|
| Organization name |
Zhangzhou municipal hospital of Fujian province
|
| Street address |
59, Shengli Road
|
| City |
Zhangzhou |
| ZIP/Postal code |
363000 |
| Country |
China |
| |
|
| Platforms (1) |
| GPL10999 |
Illumina Genome Analyzer IIx (Homo sapiens) |
|
| Samples (2) |
| GSM903660 |
peripheral blood from sample 1, primary tumor |
| GSM903661 |
peripheral blood from sample 2, remission |
|
| Relations |
| BioProject |
PRJNA157037 |
| SRA |
SRP011977 |
